Burning Rock Biotech (BNR) vs Personalis (PSNL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Personalis (PSNL) has outperformed Burning Rock Biotech (BNR) over the past year, gaining 85.0% versus a gain of 70.8%. Over five years, PSNL leads with a -19.5% price change compared with -89.4% for BNR. Personalis is the larger company by market cap ($1.71 billion vs $166.8 million), about 10.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNR | PSNL |
|---|---|---|
| Share price | $15.82 | $16.06 |
| Market cap | $166.84M | $1.71B |
| 1-day change | +5.47% | -0.03% |
| YTD return | -24.57% | +101.76% |
| 1-year return | +70.79% | +85.02% |
| 5-year return | -89.42% | -19.46% |
| EPS (TTM) | $-0.80 | $-1.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $69.65M |
| Revenue growth (YoY) | — | -17.69% |
| Net income (latest FY) | — | $-81.27M |
| Gross margin | — | 22.65% |
| Operating margin | — | -126.43% |
| Net margin | — | -116.69% |
| 52-week high | $41.72 | $18.89 |
| 52-week low | $6.79 | $4.96 |
| Distance from 52-week high | -62.08% | -15.01% |
| Analyst consensus | — | hold |
| Avg. price target upside | — | -5.51% |
| Average volume | 28.59K | 3.53M |
| Shares outstanding | 8.81M | 106.80M |
| Employees | 667 | 259 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Personalis is about 10.3 times larger than Burning Rock Biotech by market value ($1.71B vs $166.84M).
- PSNL has outperformed BNR by 14.2 percentage points over the past year.
About Burning Rock Biotech
BNR stock →Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
Health Care · Medical Specialities · 667 employees
About Personalis
PSNL stock →Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
Health Care · Medical Specialities · 259 employees
BNR vs PSNL FAQ
Which is bigger, Burning Rock Biotech or Personalis?
Personalis (PSNL) is larger, with a market capitalization of $1.71B compared with $166.84M for Burning Rock Biotech (BNR).
Which stock has performed better over the past year, BNR or PSNL?
PSNL returned +85.02% over the past 12 months, compared with +70.79% for BNR (price return, excluding dividends). Past performance does not predict future results.
Are Burning Rock Biotech and Personalis in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.